Smith Group buys 40,114 Regeneron shares worth $30.4 million
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Smith Group Asset Management LLC acquired 40,114 shares of Regeneron Pharmaceuticals valued at roughly $30.4 million, making it a significant portfolio holding. Analysts rate the stock a Moderate Buy with an average price target of $847.90, and the company recently beat earnings and revenue estimates.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.